low floater here....somebody may hit that $5 ask in the pm.

Now my plan is to wait for the shares to settle after additional 12 mil shares are added to the OS.....and see how much money they had to burn through with the bullshit lawsuit. At least the market knows they have financing now.....and that is a good thing.

No webcast for the Vote?

Jeff, I think the CGP deal will pass today.....and stock will go to $2.50.

ONTX starting pre approval sales of rigosertib now. https://www.selleckchem.com/products/ON-01910.html

Probably see a retest of .30........huge volunme todaywith equal selling moving it back down a bit.

the dhillons have screwed emerald shareholders just like they did to oncosec shareholders....VFF is the clear winner in this dispute. VFF management is superior to emerald management. the dhillons only know how to dilute shareholders.

here is the oncosec abstract. they are achieving 27% response rate compared to pembro monotherapy at 5%. https://www.abstractsonline.com/pp8/#!/7946/presentation/1035

we are about to rocket higher! This is good news today!

The problem here at Oncosec is not the data, which has always been good.....it is management. I fully expect tnbc to wow the market in December.

Oh Yeah, they are still involved here probably because Emerald Health is having financial problems Punit might need to come back to his old job....sin Dan dropped the fuckin ball maybe that would be a good thing. What a wet noodle he turned out to be.

You got that right Jeff.

Not sure why Oncosec is underplaying this potential with Merck. The sec filing which has extensive disclosures due to the CGP proposal even say that tnbc is not factored into anything. Initial data was good and it got Merck's attention....they are very interested in TNBC.

Lets just wait for the tnbc data in December and see what Merck's reaction to it is. If it is good we will see plans start for a registration trial with Merck. Maybe an equity contribution from then.....could happen.

Alpha Holdings prevails in court! I am voting for Alpha Holdings....fuck the CGP deal and dlution.

Get ready for a strong run up to TNBC data. Actually this is pretty big and the market is not factoring it in. This is the trial Merck actually put their name on as a co-sponsor with Oncosec unlike the Pisces trial. If Merck likes the data we might see the birth of a new agreement between Merck and Oncosec. TNBC is being completely overlooked and not figured into Oncosec estimates for future revenue or valuation in any deal with CGP if that closes.

Emerald Health biggest problem is they are run by the Dhillons....they speciallize in shareholder dilution. VFF on the other hand has strong management with excellent capital structure, minimal dilution. This is a fact. VFF will end up owning Pure SunFarms. Dump EMHTF and buy VFF is my opinion here. I have been in Oncosec run by the Dhillons for years....run into the ground.

I do hope the CGP deal gets approved even though the stock would likely take a short term hit. What we would have after that would be a large amount of shares locked up by insiders so any positive data with tnbc or Pisces would likely rocket the share price higher.

Seems Oncosec is desperate for funding or they would not give away 53% of the company at $2.50 with the hope for a buyout within 12 months. It would all depend on the data next year.....so they are asking shareholders that have been burned here severely for faith in management. Waiting for the shares to drop back to $1.60 would make a buyout at $4.50 much more appealing to get money back from being raped for years here.

Over the next few weeks Oncosec management will convey more details about the CGP deal.....we wait and see what else they have to say.

I hope a buyout happens next year and this CGP deal is not smoke and mirrors....because if it drags on past next year then we are looking at more dilution.

I guess we wait and see how this plays out. If CGP deal does go through it will be huge dilution soon, so if a buyout does not happen then we better get some really good news in tnbc and Pisces data soon.

I think Merck may not be as interested in the current Tavo platform for melanoma if the borr is 17%....maybe or maybe not gets the approval....and if it does who much market penetration can Tavo see and how much real money would this equate to for Merck. The Chinese and Koreans are willing to take a loss and invest in the Next_Gen Platform which is still pre clinical....so the CGP deal is probably the best thing that will happen here in the next year.....but I do think the shares will drift lowere before a buyout is entertained. I hope a buyout does happen here and be done with this.

I agree....just don't understand wht Merck has never taken any equity stake in Oncosec after all these years. I am stumped.

If this is the case and Oncosec has really no intention of selling the company, then we have funding of $30 mil + 12.2 mil shares added to the count.....this is dilution so the data better be good or next year we see another dilution. We need Pisces to enroll faster and get to an approval....so far delays have killed this stock.

could simply all be eye candy to get the $30 mil funding then no buyout and another dilution next year.....the sec filings do say CGP can take part in future equity offerings....sound familiar....Alpha wordings last year....look how that turned out for them.

Nope, the bottom price would be $4.50.....if they did a buyout. You have to factor in the dilution.....overall sharecount going from 10 mil to 22.2 mil has got to drop the stock a bit in the short-term with months and months for shareholders to ponder if a deal will actually happen....we know the drill....people really tire of Oncosec quickly. Take the cheap shares when they drop. I do think a buyout will happen next year, Dan wants to retire with a golder parachute.

If CGP owns 53% of Oncosec shares and the board puts a buyout to vote by shareholders.....how does it not pass if CGP owns majority share?.....$4.50 seems like the likely buyout price if the deal is passed....so I urge shareholders to view this with extreme caution and wait for dilution to settle at $1.60 area , then buy shares for the inevitable takeover at $4.50 next year.

could be you are right, then probably drift back down when interest wanes again.

I am voting yes to this deal but I think the stock will drop a bit before any deal is done. This deal is probably the best that Oncosec can get at this point.

just being honest here, a lower stock is coming with this dilution before it moves higher. Torreya Partners solicited by Oncosec for financial advice on this deal places the stock value at $1.60 after dilution.....says it right in the proxy filing. Oncosec can see a higher stock price into next year but the dilution is going to hit first....it is a guarantee. If this deal does not pass they will do another raise at or below current market price,,,,they need money very soon.

still feels like smoke and mirrors here at Oncosec.....I would certainly wait for the dilution to pass and see where the market is pricing the shares around December and tnbc preliminary data so we see if there is any more positive data to actually spark more buyout interest besides the Pisces trial next year....data hopefully will reach 100 patient or we see a delay and more dilution before any real buyout happens.

In my mind it would be safer to wait for the 12 mil share dilution to be factored in here before adding shares. They just lowered the upside potential that most were expecting here. I would buy again around $1.50 range. 10 mil shares oustanding to 22.2 mil is alot of dilution right off the bat....the prosepcts should be better than this.

yeah, I am confused by the calculation here. CGP could buy the company for $7.70 if the share price is $7.00....? 110% over last days trading price....market is getting confusing signals again from Oncosec....can they be more confusing? Also....seems Oncosec has maintained the irght to not sell the company....so this could end up just being $30 mil equity raise with major dilution to current shareholders with the HOPE and TRUST Oncosec is presenting....that they will not turn around and screw shareholders again....this time is different right? wow. Hard to put faith in this management at all.

read the filing from yesterday folks. Short-term dilution is definitely coming if ths deal passes. Read the financial advisor section....with whom they are paying oner $1 mil for advice. Implied value of shares after dilution will be somewhere below current stock price.....as low as in the $1.40's possibly. I would wait to buy weakness. If TNBC and PISCES goes well next year then the shares will be in good shape.....dilution will bew coming bwefore that though, it is a guarantee.

Alpha Holdings of course opposes this deal with CGP because basically it cuts them completely off from gettin back their loses....they are down 90%. Oncosec future is data dependent and Pisces must be completed without any more delays....and that is a tall order right now. They need 100 completed patient data "evaluable data" or they will dilute again.

In any case Alpha is currently the largest Oncosec shareholder, CGP doesn't own shit yet. Alpha is probably thinking having a board seat at Oncosec doesn't mean shit and now they are ready to fight to stop any more back stabbing.....this company really has been a letdown. The science is very good but management has fuckedup repeatedly doing shady activity. Dan O' Connor is not the CEO I expected would take Oncosec to th enext level.

going back to pre CGP announcement $1.60's area......Alpha Holdings is pissed!....like therest of the longs who are down 90%

Bull train aint leaving the station yet, read the Alpha sec filing today. They are opposed to the CGP deal and are going to fight this. Looks like they are preparing for a lawsuit against Oncosec.

Oncosec burns around $6 mil every 3 months and they have a history of raising cash when they hit below $20 mark. Dilution definitely on the horizon again soon.